InsiderClue
Insiders · Profile

BONNEY MICHAEL W

Director at ALNYLAM PHARMACEUTICALS · Director at Bristol Myers Squibb · Director at Sarepta Therapeutics · and 4 more. Filing since 9 Mar 2012. CIK 0001219016

ALNY ALNYLAM PHARMACEUTICALS, INC. Director · 6 trades BMY Bristol Myers Squibb Director · 1 trade SRPT Sarepta Therapeutics, Inc. Director · 1 trade THW abrdn World Healthcare Fund Director · 1 trade THQ abrdn Healthcare Opportunities Fund Director · 1 trade HQL abrdn Life Sciences Investors Director · 1 trade HQH abrdn Healthcare Investors Director · 1 trade
Company
Date
Role
Action
Shares
Amount
Of holding
ALNY ALNYLAM PHARMACEUTICALS, INC.
18 Aug 2025
Director
Sold on a plan
11,250
$5.06M
40.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
15 May 2025
Director
Sold on a plan
11,250
$3.12M
40.1%
ALNY ALNYLAM PHARMACEUTICALS, INC.
27 Dec 2023
Director
Sold on a plan
30,000
$5.85M
65.2%
ALNY ALNYLAM PHARMACEUTICALS, INC.
3 Aug 2023
Director
Sold at will
6,448
$1.20M
28.7%
BMY Bristol Myers Squibb
4 Dec 2019
Director
Bought
88
$5.18K
1.2%
SRPT Sarepta Therapeutics, Inc.
9 Sep 2019
Director
Bought
2,000
$173.48K
39.6%
ALNY ALNYLAM PHARMACEUTICALS, INC.
9 Mar 2016
Director
Bought
2,000
$116.72K
100%
THW abrdn World Healthcare Fund
17 Aug 2015
Director
Bought
10,917
$200.29K
opened
ALNY ALNYLAM PHARMACEUTICALS, INC.
12 May 2015
Director
Bought
2,000
$224.32K
opened
THQ abrdn Healthcare Opportunities Fund
28 Jul 2014
Director
Bought
5,000
$100.00K
opened
HQL abrdn Life Sciences Investors
9 Mar 2012
Director
Bought
800
$10.60K
opened
HQH abrdn Healthcare Investors
9 Mar 2012
Director
Bought
650
$10.27K
opened
12 decisions on file.